NCT03137966View on ClinicalTrials.gov

Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

December 30, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Deferoxamine

Deferoxamine (0.66mg/ml) will be applied locally as a gel (3 times a week) for a period of maximum three months or until intact skin.

DRUG

Placebo

Placebo will be applied locally as a gel (3 times a week) for a period of maximum three months or until intact skin.

All Listed Sponsors
lead

Karolinska University Hospital

OTHER